A Study of Belotero® Intense Lidocaine for Lip Augmentation
Public ClinicalTrials.gov record NCT05773066. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Multicenter, Randomized, Comparator-controlled, Evaluator-blinded Study to Evaluate the Safety and Effectiveness of Belotero® Intense Lidocaine for Lip Augmentation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to demonstrate the safety and effectiveness of Belotero Intense Lidocaine (BIL) for lip augmentation in subjects with upper and/or lower lip deficit.
Study identification
- NCT ID
- NCT05773066
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 220 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2, 2023
- Primary completion
- Oct 15, 2023
- Completion
- Sep 25, 2024
- Last update posted
- Aug 17, 2026
2023 – 2024
United States locations
- U.S. sites
- 13
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Merz Investigation Site #0010463 | Redondo Beach | California | 90277 | — |
| Merz Investigation Site #0010299 | Santa Monica | California | 90404 | — |
| Merz Investigation Site #0010358 | Vista | California | 92083 | — |
| Merz Investigation Site #0010170 | Washington D.C. | District of Columbia | 20037 | — |
| Merz Investigation Site #0010101 | Coral Gables | Florida | 33146 | — |
| Merz Investigation Site #0010464 | Alpharetta | Georgia | 30005 | — |
| Merz Investigation Site #0010446 | Atlanta | Georgia | 30342 | — |
| Merz Investigation Site #0010466 | Chicago | Illinois | 60654 | — |
| Merz Investigation Site #0010472 | Purchase | New York | 10577 | — |
| Merz Investigation Site #0010468 | Ardmore | Pennsylvania | 19003 | — |
| Merz Investigation Site #0010097 | Nashville | Tennessee | 37215 | — |
| Merz Investigation Site #0010322 | Austin | Texas | 78746 | — |
| Merz Investigation Site #0010467 | Austin | Texas | 78746 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05773066, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 17, 2026 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05773066 live on ClinicalTrials.gov.